# AltaValve Early Feasibility Study Protocol

> **NCT03997305** · NA · UNKNOWN · sponsor: **4C Medical Technologies, Inc.** · enrollment: 15 (estimated)

## Conditions studied

- Mitral Regurgitation
- Mitral Insufficiency
- Mitral Valve Incompetence
- Mitral Valve Regurgitation
- Mitral Incompetence

## Interventions

- **DEVICE:** AltaValve

## Key facts

- **NCT ID:** NCT03997305
- **Lead sponsor:** 4C Medical Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-04
- **Primary completion:** 2025-09
- **Final completion:** 2025-09
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2023-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03997305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03997305, "AltaValve Early Feasibility Study Protocol". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03997305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*